What can we learn about pulmonary infection from studying the microbiome in CF?

Yvonne Huang (Ann Arbor, United States of America)

Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research?
Session: What can respiratory medicine learn from cystic fibrosis research?
Session type: Hot topics
Number: 3295

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yvonne Huang (Ann Arbor, United States of America). What can we learn about pulmonary infection from studying the microbiome in CF?. International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is an elaborate bronchial sepsis screen in investigating recurrent respiratory infections worthwhile?
Source: Eur Respir J 2002; 20: Suppl. 38, 609s
Year: 2002

What is bacterial colonisation in COPD?
Source: Eur Respir Monogr 2015; 69: 161-171
Year: 2015


How does the gut microbiota regulate immune responses in the airways?
Source: Annual Congress 2006 - Can environmental exposures prevent allergic disease, what are the mechanisms and how important is timing of exposure?
Year: 2006


The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012


The gut microbiota state in patients with pulmonary tuberculosis.
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021


How important is work as a risk for lung infections? A story of tuberculosis and pneumonia
Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working?
Year: 2020


Viral, bacterial or both? Regardless, we need to treat infection in COPD
Source: Eur Respir J 2014; 44: 11-13
Year: 2014


Treating infection or the whole microbiome: which microbes do not matter?
Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas
Year: 2017


The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020


Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014



Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis
Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs
Year: 2018


The environment and the gut microbiome - interesting association or a rich field for future therapies?
Source: International Congress 2018 – Infectious agents and childhood asthma
Year: 2018


Does aging make alterations in pulmonary tuberculosis?
Source: Annual Congress 2003 - Clinical aspects of tuberculosis
Year: 2003


Applying ecological theories in lung microbiome research: lessons learned from microbial ecology and evolution?
Source: Eur Respir Monogr 2019; 83: 50-66
Year: 2019


Is it really time to look at distal airways to improve asthma phenotyping and treatment?
Source: Eur Respir J 2011; 38: 1252-1254
Year: 2011


The early-life microbiome: the key to respiratory health?
Source: Eur Respir Monogr 2019; 83: 67-87
Year: 2019


Antifungals in pulmonary infections: to whom, when and how?
Source: Eur Respir Monogr 2017; 75: 159-184
Year: 2017